Details

NameSymbolSector
SAMRAT PHARMACHEM LTD.SAMRATPHPharmaceuticals
Open
248.5
High
249.9
Low
228.35
Close
231.2
Volume
3211
Exchange
bse
Time
14-Aug-2026

Outlook

Score:  

1

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Samrat Pharmachem is  
Opening Marubozu
Estimated Stoploss of Samrat Pharmachem is ₹  
249.9
Samrat Pharmachem has a  
Bearishℹ
 pattern. 
Formation of  
Opening Marubozu
 candle pattern indicates Samrat Pharmachem has chances of  
Continuationℹ
 of the current trend. 

Trend

Samrat Pharmachem is in  
Sideways trendℹ
. 
Price of Samrat Pharmachem is  
Downℹ
 by  

3.61

%. 
Target
Buy @ 

186.68

Sell @ 

276.04

Current @ 

231.2

Volume

The trade volumes of Samrat Pharmachem have been  
Underperformingℹ
The volume trend for Samrat Pharmachem is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Samrat Pharmachem is  

Down

 by  

2.54

% 

Valuation

The current market price of Samrat Pharmachem is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 121cr and total assets worth ₹ 121cr, the balance sheet of Samrat Pharmachem is:  
Balancedℹ
. 
Cashflow
Samrat Pharmachem has  
Badℹ
 cash flow because there is  

Shortage

 of  

₹ 9cr

. It is  
Downℹ
 by  

350

%. 

(*Mar 2025)

100% i.e. ₹ 10cr spent in operatingℹ
0% in investingℹ
0% in financingℹ
0% in otherℹ
Samrat Pharmachem has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 2cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

45% i.e. ₹ 9cr earned in operatingℹ
0% in investingℹ
55% i.e. ₹ 11cr spent in financingℹ
0% in otherℹ
Income
The income of Samrat Pharmachem is  

₹ 78cr

 and  

Loss

 is :  

₹ 0cr

(*Sep 2025)

Samrat Pharmachem Losses increased by:  

0

% and Income is Up by:  

2.63

% 

(*Sep 2025)

The income of Samrat Pharmachem is  

₹ 76cr

 and  

Loss

 is :  

₹ 0cr

(*Jun 2025)

Samrat Pharmachem Losses increased by:  

0

% and Income is Up by:  

7.04

% 

(*Jun 2025)

The income of Samrat Pharmachem is  

₹ 71cr

 and  

Loss

 is :  

₹ 0cr

(*Mar 2025)

Samrat Pharmachem Losses increased by:  

100

% and Income is Up by:  

12.7

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.